Stonepine Capital Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.2K Sell
31,387
-72,913
-70% -$183K 0.04% 85
2026
Q1
$222K Sell
104,300
-201,100
-66% -$390K 0.09% 70
2025
Q4
$467K Buy
+305,400
New +$507K 0.34% 49

Other funds holding CGEN

Stonepine Capital Management's CGEN Position: Q2 2026 in Review

Stonepine Capital Management reduced its Compugen (CGEN) stake by 70% in Q2 2026, selling an estimated $183K and leaving 31,387 shares worth $67.2K. The position accounts for 0.04% of the portfolio, ranked #85.

Stonepine Capital Management first reported a position in CGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $467K in Q4 2025. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Stonepine Capital Management held 31,387 shares of Compugen worth $67.2K as of Q2 2026.
  • Stonepine Capital Management sold 72,913 Compugen shares in Q2 2026, an estimated $183K.
  • Compugen made up 0.04% of Stonepine Capital Management's portfolio in Q2 2026, its #85 holding.
  • Stonepine Capital Management first reported a position in Compugen in Q4 2025 and has held it in 3 quarters since.
  • Stonepine Capital Management's Compugen position peaked at $467K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.